Picture of TalkMed logo

5G3 TalkMed Cashflow Statement

0.000.00%
sg flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Annual cashflow statement for TalkMed, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line41.324.827.336.837.8
Depreciation
Non-Cash Items0.2726.320.77631.77
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-9.16-3.36-7.39-5.1-0.647
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities35.931.323.237.341.7
Capital Expenditures-2.13-1.95-0.77-4.33-0.704
Purchase of Fixed Assets
Other Investing Cash Flow Items0.125-6.49-1.21-0.6860
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2-8.45-1.98-5.01-0.704
Financing Cash Flow Items1.882.512.802.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-27.2-24.1-18.4-33.9-31.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6.71-1.272.73-1.589.31